No Data
Vivani Medical Unit Cortigent Expects IPO of 1.5M Shrs to Price at $10 Each
Independent Chairman of the Board of Vivani Medical Gregg Williams Buys 30% More Shares
Vivani Medical Gains 'Buy' Rating Due to Strategic Advancements and Financial Strength
Vivani Medical Reports Q3 Loss, Advances GLP-1 Trials
Vivani Medical Secures Funding for GLP-1 Implant Trial
10-Q: Q3 2024 Earnings Report